• $17.2M
    Market Cap
  • -83.43%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
8.9M
+4.48%
8.6M
+20.48%
7.1M
-42.87%
12.4M
-74.03%
Research and Development Expense
-3.5M
-40.12%
-5.8M
-10.33%
-6.5M
-26.61%
-8.8M
-8.13%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
8.9M
+4.48%
8.6M
-36.90%
13.6M
-36.13%
21.3M
-55.64%
Operating Profit
-12.4M
-13.52%
-14.4M
+5.80%
-13.6M
-36.13%
-21.3M
-63.04%
Interest Income
123,000
-69.40%
402,000
-48.46%
780,000
+167.12%
292,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
-213,000
+2,562.50%
-8,000
N/A
Interest Income and Expense and Net
123,000
-69.40%
402,000
-29.10%
567,000
+99.65%
284,000
N/A
Total Nonoperating Income and Expense
-15.9M
-1,425.46%
1.2M
-79.90%
6.0M
+1,502.95%
373,000
+174.90%
Income before Taxes
-34.4M
+139.83%
-14.4M
+5.80%
-13.6M
-36.13%
-21.3M
-63.04%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-34.4M
+161.73%
-13.2M
+73.25%
-7.6M
-63.62%
-20.9M
-64.00%
Net Income from Continuing Operations Applicable to Common
-34.4M
+161.73%
-13.2M
+73.25%
-7.6M
-63.62%
-20.9M
-64.00%
Basic EPS and Net Income
-6.68
-3.75%
-6.94
+23.05%
-5.64
+754.55%
-0.66
-67.96%
Diluted EPS and Net Income
-6.68
-3.75%
-6.94
+23.05%
-5.64
+754.55%
-0.66
-67.96%
Basic Weighted Average Shares
5.5M
+190.57%
1.9M
+40.78%
1.3M
-95.77%
31.9M
+13.19%
Diluted Weighted Average Shares
5.5M
+190.57%
1.9M
+40.78%
1.3M
-95.77%
31.9M
+13.19%
Balance Sheet
Cash and Cash Equivalents
6.8M
+72.39%
4.0M
+266.17%
1.1M
-80.98%
5.7M
-36.75%
Short-Term Investments
N/A
N/A
N/A
N/A
12.9M
+18.98%
10.8M
-52.91%
Cash and Cash Equivalents and Short-Term Investments
6.8M
+72.39%
4.0M
-71.72%
14.0M
-15.36%
16.5M
-48.38%
Total Current Assets
8.1M
+91.54%
4.2M
-69.89%
14.1M
-15.13%
16.6M
-48.52%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
634,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
8.1M
+91.54%
4.2M
-70.00%
14.1M
-15.70%
16.7M
-47.97%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
2.5M
+7,964.52%
Total Current Liabilities
2.3M
-60.71%
5.9M
-11.02%
6.6M
+34.33%
4.9M
-51.87%
Total Long-Term Debt
N/A
N/A
N/A
N/A
1.0M
-98.41%
62.9M
+30.23%
Total Long-Term Liabilities
150,000
-97.41%
5.8M
-90.19%
59.1M
+92,243.75%
64,000
N/A
Total Liabilities
2.3M
-60.71%
5.9M
-11.02%
6.6M
+32.61%
5.0M
-51.24%
Retained Earnings
-723.9M
+4.12%
-695.2M
+1.93%
-682.1M
+1.13%
-674.5M
+3.20%
Total Stockholders Equity
N/A
N/A
-1.7M
-122.34%
7.5M
-36.29%
11.7M
-46.44%
Total Shares Outstanding
25.5M
+1,042.81%
2.2M
+61.83%
1.4M
-95.78%
32.7M
+2.06%
Cash Flow
Cash from Operating Activities
-12.9M
+0.08%
-12.9M
+45.77%
-8.9M
-41.83%
-15.2M
-2.49%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
12.9M
+741.76%
-2.0M
-116.54%
12.1M
+152.71%
Dividends Paid
229,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
15.8M
+430.07%
3.0M
-52.52%
6.3M
+2,898.21%
-224,000
-100.53%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-558.42%
+289.07%
-143.53%
+191.37%
-49.26%
-42.32%
-85.41%
-72.15%
Return on Equity
N/A
N/A
-453.39%
+473.23%
-79.09%
-36.29%
-124.15%
-108.05%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.50
+387.52%
0.72
-66.16%
2.12
-36.82%
3.35
+6.96%
Cash Ratio
2.94
+338.75%
0.67
+311.43%
0.16
-85.83%
1.15
+31.39%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
5.57
+152.66%
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
3.91
+160.10%

Earnings & Revenue History

Debt-to-Assets

Cash Flow